Skip to main content

Table 2 Patient and SBRT treatment characteristics (n = 25 patients)

From: Predictive factors for response to salvage stereotactic body radiotherapy in oligorecurrent prostate cancer limited to lymph nodes: a single institution experience

Characteristics

Value

Age at SBRT (years)

 median (IQR)

68

(62–72)

 mean (range)

68

(52–81)

PSA at SBRT (ug/l)

 median (IQR)

3.53

(1.48–6.86)

 mean (range)

3.49

(1.02–14.54)

PSADT

  < 3 months

5

20%

 3–6 months

12

48%

  > 6 months

8

32%

Number of lymph nodes at SBRT

 1

16

64%

 2

7

28%

 3

2

8%

LN localisation (n = 36)

 N1

33

92%

 M1a

3

8%

Largest LN diameter (mm)a

 median (IQR)

10.5

(8.5–13.5)

 mean (range)

12.8

(5–33)

SBRT data (Gy)

 total median dose (range)

36

(30–45)

 median dose per fraction (range)

12

(10–15)

SBRT regimen

 10 Gy per 3 fractions

2

8%

 11 Gy per 3 fractions

1

4%

 12 Gy per 3 fractions

11

44%

 13 Gy per 3 fractions

7

28%

 15 Gy per 3 fractions

4

16%

  1. a one data missing (n = 35)